Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections

Bergen, Norway, February 7, 2024, – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that Dr. Mirella Spalluto of the University of Southampton today presented “Investigating the effects of AXL inhibition during respiratory viral infections” during the 6th Forum on Respiratory Infections in Glasgow, Scotland. The data presented by Dr. Spalluto showed bemcentinib had activity in human in vitro models of infection caused by Respiratory Syncytial Virus (RSV), influenza and

Year end report 2023

2023 ended with increased rental income, improved operating income, strengthened surplus ratio and improved management result. Net letting amounted to SEK 165m, one of the strongest ever for Fabege. Higher interest costs and negative value changes in the property portfolio meant that the result after tax decreased compared to the previous year.· Rental income increased to SEK 3,336m (3,032). On a like-for-like basis, rental income increased by just over 11 per cent (5). · Net operating income increased to SEK 2,524m (2,240). On a like-for-like basis, net operating income increased by 14

Valmet’s Financial Statements Review January 1 – December 31, 2023: Orders received amounted close to EUR 5.0 billion and Comparable EBITA increased to EUR 619 million in 2023

Valmet’s Financial Statements Review January 1 – December 31, 2023: Orders received amounted close to EUR 5.0 billion and Comparable EBITA increased to EUR 619 million in 2023 Valmet Oyj’s stock exchange release on February 7, 2024 at 1:00 p.m. EET Figures in brackets, unless otherwise stated, refer to the comparison period, i.e., the same period of the previous year. October–December 2023: Net sales remained at the previous year's level, Comparable EBITA decreased •         Orders received decreased 17 percent to EUR 1,155 million (EUR 1,385 million). –        Orders

Impala Bondco plc - Initiates a written procedure and provides financial updates

Nottingham, 7 February 2024 - Impala Bondco Plc (the "Company") has instructed the agent for the Company's up to SEK 500,000,000 senior secured bonds with ISIN NO0011117145 (the "Bonds") to initiate a written procedure to request the holders of the Bonds to, amongst other things, vote in favour of amending the terms and conditions of the Bonds (the "Terms and Conditions"). As announced on 19 January 2024, the Company has not made its latest scheduled payments of interest under the Bonds resulting in the occurrence of an event of default under the terms and conditions of the Bonds (the "

Konecranes’ climate work earns Leadership ranking from the CDP for a second consecutive year

Konecranes received an A- rating in the annual climate program of the CDP for a second straight year, reflecting its efforts and commitment to be a material handling industry leader in cutting emissions, managing and mitigating climate risks and developing a low-carbon offering. The CDP’s annual program is a globally recognized benchmark that ranks the efforts of investors, companies, cities, states and regions to manage their environmental impact. Companies receiving a Leadership ranking must demonstrate both awareness of their impact on the environment, and the appropriate actions

Salmon Evolution ASA: Invitation to presentation of results for the fourth quarter 2023

Salmon Evolution will present the fourth quarter 2023 results followed by a Q&A session, on Tuesday 13 February 2024 08:00 CET, at Hotel Continental in Oslo. A light snack will be served from 07:45 CET. Participants may also follow the presentation and submit questions through a live webcast available on www.salmonevolution.no, or with the following link: https://events.webcast.no/salmon-evolution/OEpmPDaoyhi5siPjdg0b/4XiwthqLH2GoUCaGlEfL The presentation and Q&A will be held in English by CEO Trond Håkon Schaug-Pettersen and CFO Trond Vadset Veibust. Please note that the quarterly

Blocklisting - Interim Review

BLOCK LISTING SIX MONTHLY RETURN   Information provided on this form must be typed or printed electronically and provided to an ris.   Date: 7 February 2024   +---------+-----+-------------+---+-------------------+|Name of |Fidelity Special Values PLC ||applicant: | |+---------+-----+-------------+---+-------------------+|Name of |General Corporate Purposes ||scheme: | |+---------+-----+-------------+---+-------------------+|Period of|From:|8

1Vision Biogas publishes supplement to the offer document regarding the mandatory cash offer to the shareholders of Biokraft

The Offer is not being made, and this press release may not be released, distributed or published, in whole or in part, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which the making of the Offer, the release, distribution or publication of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

Oslo, 7 February 2024: Reference is made to the stock exchange announcement by Circio Holding ASA (OSE:CRNA) (“CIRCIO” or the “Company“) on 5 February 2024, regarding the requested conversion of convertible bonds by Atlas Special Opportunities, LLC. The share capital increase has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company’s new share capital is NOK 4,660,284.60 divided into 7,767,141 shares, each with a nominal value of NOK 0.60.

Highlights of Stadshypotek’s Annual Report January–December 2023

JANUARY–DECEMBER 2023 COMPARED WITH JANUARY–DECEMBER 2022Stadshypotek’s operating profit decreased by SEK 3,589m, or 28%, to SEK 9,298m (12,887). Net interest income fell by SEK 2,767m to SEK 12,212m, (14,979), mainly due to higher funding costs arising from rising market rates, and decreased margins for Swedish and Norwegian private loans. In Sweden, net interest income fell by SEK 2,020m, while in the Norwegian branch it fell by SEK 164m.   Of the net interest income, SEK 688m (852) was attributable to the branch in Norway and SEK 469m (557) to the branch in Finland. Exclud- ing the

SAS Traffic figures – January 2024

1.5 million passengers traveled with SAS during January1.5 million passengers traveled with SAS in January, a 1 percent increase compared with the same month last year. SAS’ capacity increased by 5 percent and RPK increased by 9 percent, compared with January 2023. The flown load factor for January was 70 percent. “We are pleased to see that more and more people choose to travel with SAS. To meet the increasing demand for travel, we released our summer program in January, adding several new and exciting destinations in Scandinavia, Europe and the US. We also announced a new collaboration

Essity included in S&P Global’s Sustainability Yearbook 2024

Hygiene and health company Essity has, for the third consecutive year, been included in S&P Global’s Sustainability Yearbook. In the review of more than 9,400 companies worldwide, Essity is part of the top 10% to be selected for this year’s Yearbook.S&P Global is an international finance and analytics company that annually reviews the world’s most sustainable companies. Each company answers a comprehensive questionnaire that is analyzed alongside public environmental, social and governance (ESG) data.  “Every day, over a billion people use our products, services and solutions. Thanks to

OncoZenge Files Patent Application for Strengthened IP Protection for BupiZenge™

Stockholm, February 7, 2024 – OncoZenge AB (publ) today announces that the company has filed a new patent application with the Swedish Patent and Registration Office (PRV). The patent strengthens the protection of the second generation of BupiZenge™ and the innovations made in connection with the recent reformulation. The new patent will provide strengthened IP protection for strategic partners and licensees upon approval.In line with OncoZenge's strategy, the company has assessed the opportunities for complementary patents that further strengthen the protection for the second generation

BiBB Receives European CE Mark Approval According to MDR for the Entire EndoDrill Product Family

The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), which has developed the world's first electric-driven endoscopic biopsy instrument, announces that the Company has received CE certification for EndoDrill[®] in accordance with MDR. The market approval allows EndoDrill[®] to be introduced in Europe for all three market segments, i.e. for sampling of the gastrointestinal tract, lungs, and bladder. With the CE mark in place, the Company plans to launch EndoDrill® GI in 2024 to targeted customers. Several clinical market studies are also planned to highlight the

Researchers trialling new device to support amputees

A new medical device developed by Teesside University researchers in a pioneering project could be used to treat phantom limb pain.Teesside University collaborated with healthcare innovation company 2PD to design and develop a new medical device which could support people who have had  amputation surgery. Now completed, the device is undergoing a clinical trial to investigate its efficacy in treating phantom limb pain. Phantom limb pain occurs when amputees experience sensations which feel like they are coming from an amputated limb. It can be seriously debilitating and is a common

Tails of Romance: Study Finds Pets Playing Matchmaker for One Third of Owners

As Valentine’s Day approaches and many people prepare for a day filled with love, some singletons may wonder how to meet someone new. Dogs may be known for being man’s best friend, but they’re also statistically proven to improve their owner's social life. Perhaps even leading to a paw-fect match, according to a recent study which found that one in three dog owners have met a new partner or friend through their pet.       The research by leading animal insurer,  Agria Pet Insurance , shows that pets can help to

Aker ASA: Presentation of Fourth-Quarter Results 2023

Aker ASA will publish its financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, at 07:00 CET. An online audiocast presentation of the results will be available the same day at 09:00 CET.Audiocast details: Date: Tuesday, February 20, 2024Time: 09:00am CETFormat: AudiocastLanguage: EnglishLink: https://channel.royalcast.com/landingpage/hegnarmedia/20240220_1/    There will be a Q&A session following the presentation. Written questions can be submitted through the audiocast solution during the presentation. It is also possible to submit questions to

SSAB in Italy now runs production with fossil-free energy

SSAB Swedish Steel S.p.A, established in Ghedi, Italy in 1995, installed solar panels on the roof of their production facility at the end of 2023. The SSAB Ghedi Steel Service Center production now operates fully with fossil-free energy, supporting SSAB’s strategy towards a more sustainable world. The new steel roof for the SSAB Ghedi Steel Service Center uses a trapezoidal profile provided by Ruukki Construction, a division of the SSAB Group, and is made from sustainable GreenCoat® color coated steel. GreenCoat® color coated steels use Swedish rapeseed oil in the coating.

OKEA webcast Q4 2023

OKEA ASA will release its fourth quarter 2023 results tomorrow Thursday 8 February 2024 at 06.00 CET. A presentation of the results will be held the same day through a webcast and audioconference starting 11:00 CET. The presentation will be held by Svein J. Liknes (CEO) and Birte Norheim (CFO).The webcast can be followed at www.okea.noor OKEA Webcast Q4 2023 (royalcast.com) Dial in details for the audioconference:  DK: +45 7876 8490 SE: +46 8 1241 0952 NO: +47 2195 6342 UK: +44 203 769 6819 US: +1

SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

SmartCella, through its business unit ProCella, has been approved by the Swedish Medicinal Product Agency for manufacturing and quality control testing of sterile biological medicinal products for cell therapy.SmartCella is pleased to announce that ProCella has been granted manufacturing authorization as well as Good Manufacturing Practice (GMP) certification from the Swedish Medicinal Product Agency. The approvals signify the ability to start clinical production of cell-based therapies for clinical studies. The facility, located at SmartCella’s headquarters in Tullinge near Karolinska

GF Piping Systems earns Jiarong Technology's 2023 Excellent Supplier Award

GF Piping Systems China earned a "2023 Excellent Supplier" award from Xiamen Jiarong Technology Co. Ltd., a leading player in the Chinese membrane technology industry, for providing the company with high-quality and reliable products and services.Xiamen Jiarong Technology focuses on high-difficulty wastewater treatment, providing customers with high-end environmental protection equipment and operation services, and uses GF Piping Systems' Process Automation solutions in their mobile landfill leachate treatment system. Five "2023 Excellent Supplier" awards were given out this January. GF

Invitation to presentation of Ranplan’s H2 interim report 2023

Stockholm, Sweden, 7 Feb, 2024Ranplan Group AB is pleased to invite media, investors, shareholders and financial analysts to a video conference meeting from its office in the city of Stockholm. On this occasion, CEO Per Lindberg and CSO Jon Ullmark will present the report for the second half and the full-year of 2023. Those who want to participate online at this event should notify the company of their interest before 6pm CET on 15 Feb 2024 by sending an e-mail to joyce.wu@ranplanwireless.com (joyce.wu@ranplanwireless.com?subject=Invitation%20to%20presentation%20of%20Ranplan%E2%80%99s%

Irisity IRIS+™ selected by SYM Servicios as the AI Open Platform for Michoacán Security Center

Irisity AB (publ), a leading provider of AI-driven video data management software, in collaboration with SYM Servicios Integrales, announces the launch of an innovative emergency operations center in Mexico. The new site is called C5 SITEC which provides centralized statewide security, intelligence and is the technology center of operations for Michoacán.[A black background with a black square Description automatically generated with medium confidence]   FOR IMMEDIATE RELEASE   Irisity IRIS+™ selected by SYM Servicios as the AI Open Platform for Michoacán Security Center

Rightbridge to Use World-Famous Pistol for Healthier Gaming and Esports Behavior - Signs Licensing Agreement with Non Violence on Knot OK

Rightbridge Ventures Group AB (publ) ("Rightbridge" or "the Company") has, through its wholly owned subsidiary Gaming Guardians AB ("Gaming Guardians" or "GG"), entered into a licensing agreement with Non Violence Licensing SA ("NVLSA") for the rights to the Knot OK brand and the symbol "Knotted Gun" - the world-famous pistol with a knotted barrel. The symbol will be used to promote better - less toxic - gaming within gaming and esports. The agreement lasts for three years with the option to extend for another five years, where GG will pay a licensing fee of about 340k SEK in 2024 and about

There are no items matching the current filter
There are no more items matching the current filter
Back to top